At the news
? NEUTRALIMPACT 3/10 144 filed Mar 27, 2026 at 16:41 ET
Joanne Donovan, an officer of Edgewise Therapeutics, filed a Form 144 to notify intent to sell up to 71,588 shares of common stock. The shares were acquired through stock option exercises, an employee stock purchase plan, and restricted stock unit vesting.
- Joanne Donovan, an officer of Edgewise Therapeutics, intends to sell up to 71,588 shares.
- The shares consist of 50,000 from stock option exercises, 9,623 from an employee stock purchase plan, and 11,965 from restricted stock unit vesting.
- The filing was submitted on March 27, 2026, with the sales expected to occur over the next three months.
- No immediate sale has been reported; this is a notice of proposed sale.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access